MIRA INFORM REPORT

 

 

Report No. :

327113

Report Date :

15.06.2015

 

IDENTIFICATION DETAILS

 

Name :

EMS S/A

 

 

Registered Office :

Rod Jornalista Francisco Aguirre Proenca, S/Nº, KM,8 Bloco I, II E V - Chacara Assay, 13.186-901 - Hortolandia/SP

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

09.01.1964

 

 

Legal Form :

Privately Held Corporation

 

 

Line of Business :

Manufacture and Trader of pharmaceuticals products

 

 

No of Employees :

4061

 

 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Exist

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Brazil

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

B2

Moderate High Risk

 

C1

High Risk

C2

Very High Risk

D

 

BRAZIL - ECONOMIC OVERVIEW

 

Characterized by large and well-developed agricultural, mining, manufacturing, and service sectors, and a rapidly expanding middle class, Brazil's economy outweighs that of all other South American countries, and Brazil is expanding its presence in world markets. Since 2003, Brazil has steadily improved its macroeconomic stability, building up foreign reserves, and reducing its debt profile by shifting its debt burden toward real denominated and domestically held instruments. Since 2008, Brazil became a net external creditor and all three of the major ratings agencies awarded investment grade status to its debt. After strong growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in 2008. Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based exports dwindled and external credit dried up. However, Brazil was one of the first emerging markets to begin a recovery. In 2010, consumer and investor confidence revived and GDP growth reached 7.5%, the highest growth rate in the past 25 years. Unemployment is at historic lows and Brazil's traditionally high level of income inequality has declined for each of the last 15 years. Rising inflation led the authorities to take measures to cool the economy in 2011; these actions and the deteriorating international economic situation slowed growth in 2011-14. Brazil’s fiscal and current account balances have eroded during the past three years as the government attempted to boost economic growth through targeted tax cuts for industry and incentives to spur household consumption. President Dilma ROUSSEFF has indicated that her government in her second term will pursue more austere fiscal policies to reduce these imbalances and preserve the country’s credit rating.

 

Source : CIA

Company name

 

EMS S/A

 

 

ADDRESSES

 

MAIN ADDRESS:

ROD JORNALISTA FRANCISCO AGUIRRE PROENCA, S/Nº, KM,8 BLOCO I, II E V - CHACARA ASSAY

ZIP CODE/CITY:

13.186-901 - HORTOLANDIA/SP

 

 

PHONE:

19 3887-9961

E-MAIL:

joaodenadal@ems.com.br

WEB SITE:

www.ems.com.br

 

BRANCHES:

 

 

 

ADDRESS:

AVENIDA A,27 A, CJ MARCOS FREIRE II - TAICOCA

ZIP CODE/CITY:

49160-000 NOSSA SENHORA DO SOCORRO/SE

CNPJ:

57.507.378/0005-27

 

 

ADDRESS:

SAA NORTE, QUADRA 02,960

ZIP CODE/CITY:

70632-200 BRASÍLIA/DF

PHONE:

61 3363-4309

CNPJ:

57.507.378/0006-08

 

 

ADDRESS:

RUA MONSENHOR OTÁVIO DE CASTRO,167 - VILA UNIÃO

ZIP CODE/CITY:

60410-691 FORTALEZA/CE

CNPJ:

57.507.378/0007-99

 

 

ADDRESS:

RUA 1.126, QUADRA 230, LOTE 2, CASAS 1 E 2,0 - SETOR MARISTA

ZIP CODE/CITY:

74175-050 GOIÂNIA/GO

CNPJ:

57.507.378/0008-70

 

 

ADDRESS:

RUA COM CARLO MARIO GARDANO,450 - CENTRO

ZIP CODE/CITY:

09.720-47 SAO BERNARDO DO CAMPO/SP

PHONE:

11 2104-1677

CNPJ:

57.507.378/0001-01

STATE REGISTER:

635.038.454.114

 

 

ADDRESS:

268 MUNOZ RIVERA AVE, WESTERNBANK WORLD PLAZA, SUÍTE,808 - SAN JUAN

ZIP CODE/CITY:

PORTO RICO, PR 00918

 

 

ADDRESS:

RUA COMENDADOR CARLO MARIO GARDANO,450 - VILA SANTA RITA DE CÁSSIA

ZIP CODE/CITY:

09720-470 SÃO BERNARDO DO CAMPO/SP

CNPJ:

57.507.378/0001-01

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE OF PHARMACEUTICALS.

 

 

LEGAL FORM:

PRIVATELY HELD CORPORATION

 

 

INCORPORATION DATE:

09/01/1964

REGISTER DATE:

09/01/1964

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

57.507.378/0003-65

STATE REGISTER:

748.002.161.113

 

 

SHARE CAPITAL:

R$ 221.716.502,41

LAST REGISTER OF CAPITAL:

26/11/2012

 

BOARD OF DIRECTORS:

 

 

 

LUIZ CARLOS BORGONOVI

PRESIDENT DIRECTOR

ISRAEL DOMINGUES BACCA

VICE-PRESIDENT DIRECTOR

DOMENICO ANTONIO GUIDA

DIRECTOR

JULIO CESAR BORGES

DIRECTOR

 

AUTHORIZED USE OF SIGNATURE

 

THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

 

SHAREHOLDERS / PARTNERS:

 

 

 

EMS PARTICIPAÇÕES S/A

99,99%

OTHRES

0,01%

 

AFFILIATES / SUBSIDIARIES:

 

 

 

LEGRAND PHARMA INDUSTRIA FARMACÊUTICA LTDA

 

NATURE´S PLUS FARMACEUTICA LTDA

 

EMS SIGMA FARMA LTDA

 

SIGMA FARMA EMS, LLC

 

CPM CONCESSIONARIA PAULISTA DE MEDICAMENTOS S/A

 

 

 

COMPANY'S BACKGROUND

 

THE HISTORY OF EMS SIGMA PHARMA GROUP STARTS IN 1964, IN THE CITY OF SANTO ANDRÉ, WHEN THE PHARMACY CALLED SANTA CATARINA WAS ESTABLISHED BY EMILIANO SANCHEZ. AFTER 13 YEARS OF HARD WORK, DEDICATION AND GROWING, THE SMALL PHARMACY WAS TRANSFORMED INTO THE LABORATORY CALLED EMS.

 

DURING THE FOLLOWING YEARS, AS PART OF THEIR EXPANSION STRATEGY, THE LABORATORIES LEGRAND AND NOVAQUÍMICA WERE PURCHASED, FURTHER TO THE EXPANSION OF THE PRODUCTS LINE AND THE SEGMENT OF ACTIVITY, COMPLETING THE COMPANY'S PORTFOLIO.

 

CURRENTLY, THE GROUP IS COMPOSED BY THE COMPANIES EMS, LEGRAND, SIGMA PHARMA AND NATURE'S, ACTING IN THE PHARMACEUTICAL, GENERIC, CONSUME, HOSPITAL AND PERSONAL HYGIENE SEGMENTS. THE GROUP HAS AS HIGHLIGHT IT PIONEER CONDITION WITH GENERIC MEDICATIONS, BEING THE FIRST COMPANY TO RECEIVE THE APPROVAL OF ANVISA TO MANUFACTURE AND MERCHANDISE THE MEDICATION CALLED CYCLOSPORINE, WHICH IS DESTINED TO AVOID THE REJECTION OF TRANSPLANT ORGANS.

 

ONE OF THE LARGEST COMPANIES WITH ASSETS CAPITAL BEING 100% NATIONAL, IN 39 YEARS OF ACTIVITY IN THE BRAZILIAN MARKET, REACHED THE 11TH PLACE IN THE PHARMACEUTICAL INDUSTRIES RANKING (SOURCE: IMS HEALTH, 2002).

 

THE GROUP HAS TWO PRODUCTION UNITS LOCATED IN SÃO BERNARDO DO CAMPO AND HORTOLÂNDIA, SP, BEING THE LAST ONE THE MOST UPDATED COMPANY OF LATIN AMERICA, STRUCTURED ACCORDING TO THE STANDARDS ESTABLISHED BY THE FDA (FOOD AND DRUG ADMINISTRATION).

 

WITH 2,800 EMPLOYEES DISTRIBUTED IN THE ADMINISTRATION, COMMERCIAL AND INDUSTRIAL AREAS, THE EMS SIGMA PHARMA GROUP MANUFACTURES AND MERCHANDISE FOR ALL THE COUNTRY MORE THAN 350 PRODUCTS, ALL OF THEM MANUFACTURED UNDER THE MOST STRICT QUALITY STANDARDS, CONTRIBUTING IN THIS WAY TO IMPROVE THE HEALTH AND QUALITY OF LIFE OF ALL BRAZILIANS

 

ON DECEMBER 17, 2002 THE SUBJECT COMPANY CHANGED ITS CORPORATE NAME FROM EMS INDÚSTRIA FARMACÊUTICA LTDA TO THE CURRENT ONE.

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

PROTESTS:

 

15  PROTESTS,TOTAL AMOUNT R$ 117.178,76

    DATE OF FIRST PROTEST: 03/2015  R$ 3.770,10

    DATE OF HIGHEST PROTEST: 04/2015  R$ 40.003,31

 

DETAILS OF LATEST PROTESTS:

 

NOTARY OFFICE:

DATE:

VALUE:

2º CARTORIO DE BRASILIA/DF

22/04/2015

R$ 1.008,98

2º CARTORIO DE BRASILIA/DF

22/04/2015

R$ 3.026,93

1º CARTORIO DE SUMARE/SP

14/04/2015

R$ 824,39

1º CARTORIO DE SUMARE/SP

14/04/2015

R$ 2.444,68

1º CARTORIO DE SUMARE/SP

14/04/2015

R$ 3.012,99

 

LAWSUITS:

 

 

 

DATE:

COURT OF LAW:

 

2

STATE LAWSUITS

13/03/13

VARA DE BRASILIA/DF

1

MUNICIPAL LAWSUIT

14/11/14

VARA DE CAMPINAS/SP

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2014, 31/12/2013 AND 31/12/2012.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

CASH AND BANKS

105.701

111.419

61.619

CLIENTS

454.283

469.178

399.103

INVENTORY

243.733

243.265

218.712

OTHER CREDITS

16.607

7.664

8.249

INTERCOMPANY CREDITS

99.303

83.591

161.594

RECOVERABLE TAXES

8.185

9.172

2.863

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

927.812

924.289

852.140

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

JUDICIAL DEPOSITS

23.183

18.011

14.961

DEFERRED TAXES

31.050

17.632

14.129

INTERCOMPANY CREDITS

66.160

1.500

 

RECOVERABLE TAXES

6.703

6.703

6.931

INVESTMENTS

2.758

24.349

21.733

OTHER CREDITS

4.996

4.996

2.640

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

134.850

73.191

60.394

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

163.297

155.085

149.936

FIXED ASSETS

370.128

307.005

235.818

INTANGIBLE

4.391

3.994

3.479

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

537.816

466.084

389.233

 

================

================

================

TOTAL ASSETS

1.600.478

1.463.564

1.301.767

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

LOANS AND FINANCING

54.929

54.026

51.825

SUPPLIERS

141.392

132.038

132.654

INTERCOMPANY DEBTS

38.860

45.739

116.567

ACCOUNTS PAYABLE

34.078

10.747

26.358

INSTALLMENTS TAXES PAYABLE

7.052

6.875

10.617

INCOME TAX/SOCIAL CONTRIBUTION

40.692

77.284

21.553

TAX LIABILITIES

152.765

45.069

30.629

SOCIAL / LABOR OBLIGATIONS

34.928

32.426

36.352

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

504.696

404.204

426.555

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

113.151

153.095

152.881

INSTALLMENTS TAXES PAYABLE

24.081

24.930

25.065

PROVISION FOR CONTINGENCIES

44.059

33.405

53.622

DEFERRED REVENUE

19.032

115.056

102.207

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

200.323

326.486

333.775

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

221.708

221.708

221.708

CAPITAL RESERVES

164.019

164.019

164.019

PROFIT RESERVES

509.732

347.147

155.710

 

----------------

----------------

----------------

TOTAL NET EQUITY

895.459

732.874

541.437

 

================

================

================

TOTAL LIABILITIES

1.600.478

1.463.564

1.301.767

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2014, 31/12/2013 AND 31/12/2012.

( FIGURES ARE IN THOUSANDS OF REAIS ).

 

 

31/12/2014

31/12/2013

31/12/2012

 

 

 

 

NET SALES

2.043.634

1.843.726

1.635.486

(-) COST OF SOLD GOODS

828.017

682.027

591.991

 

----------------

----------------

----------------

GROSS PROFIT

1.215.617

1.161.699

1.043.495

OPERATING REVENUE (EXPENSE)

-617.130

-595.257

-643.645

FINANCIAL REVENUE(EXPENSE)

-26.980

-18.717

-41.441

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

571.507

547.725

358.409

CONTRIBUTION/INCOME TAX

-106.117

-143.986

-88.978

 

----------------

----------------

----------------

NET PROFIT (LOSS)

465.390

403.739

269.431

 

RATIOS:

31/12/2014

31/12/2013

31/12/2012

 

QUICK RATIO

1,36

 

1,68

 

1,49

 

CURRENT RATIO

1,84

 

2,29

 

2,00

 

ACCOUNTS RECEIVABLE TURNOVER

4,50

TIMES

3,93

TIMES

4,10

TIMES

DAYS' SALES IN RECEIVABLES

80,03

DAYS

91,61

DAYS

87,85

DAYS

INVENTORY TURNOVER

3,40

TIMES

2,80

TIMES

2,71

TIMES

ACCOUNTS PAYABLE PERIOD

61,47

DAYS

69,69

DAYS

80,67

DAYS

RETURN ON ASSETS

1,28

TIMES

1,26

TIMES

1,26

TIMES

SALES TURNOVER ON NET EQUITY

2,28

TIMES

2,52

TIMES

3,02

TIMES

NET WORTH TIE-UP

,41

 

,42

 

,44

 

INDEBTEDNESS

,79

 

1,00

 

1,40

 

EQUITY RATIO

55,95

%

50,07

%

41,59

%

WORKING CAPITAL RATIO

83,84

%

128,67

%

99,77

%

GENERAL SOLVENCY

2,27

 

2,00

 

1,71

 

RETURN ON NET EQUITY

51,97

%

55,09

%

49,76

%

RETURN ON SALES (PROFIT MARGIN)

22,77

%

21,90

%

16,47

%

GROSS PROFIT MARGIN

59,48

%

63,01

%

63,80

%

OPERATIONAL RESULT

27,97

%

29,71

%

21,91

%

SALES TURNOVER ON LIABILITIES

4,05

TIMES

4,56

TIMES

3,83

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 2,97

 - OFFICIAL RATE ON 24/04/2015

US$ 1,00 = R$ 2,65

 - OFFICIAL RATE ON 31/12/2014

US$ 1,00 = R$ 2,34

 - OFFICIAL RATE ON 31/12/2013

US$ 1,00 = R$ 2,04

 - OFFICIAL RATE ON 31/12/2012

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A GOOD FINANCIAL STANDING. IT SHOWS HIGH LIQUIDITY RATIOS WITH POSITIVE WORKING CAPITAL AMOUNT AND SATISFACTORY LEVEL OF INDEBTEDNESS. IN ADDITION IT IS NOTED GROWING SALES AND PROFITABILITY.

 

IT IS WORTH TO COMMENT THAT THE SUBJECT HAS A HIGH FINANCIAL STRENGTH AND SO FAR IT OPERATES NORMALLY BEING NOT LIKELY TO FACE FINANCIAL PROBLEMS.

 

 

REAL ESTATE:

 

   OWNED PREMISES ARE VALUED AT R$ 727.800,00

 

DETAIL OF OWNED REAL ESTATE:

 

QUANTITY:

1

TYPE:

OTHERS

VALUE:

R$ 110.400,00

ADDRESS:

AV. ARTHUR DE QUEIROZ S/N - CASA BRANCA EM SANTO ANDRÉ/SP

 

 

QUANTITY:

1

TYPE:

BUILDING

VALUE:

R$ 736.000,00

ADDRESS:

AV. ARTHUR DE QUEIROZ, 905/915 - CASA BRANCA, EM SANTO ANDRÉ/SP

 

VEHICLES:

 

   NOT AVAILABLE

 

MACHINES:

 

   NOT AVAILABLE

 

 

INSURANCE

 

INSURANCE COMPANY:

MINAS-BRASIL SEGURADORA

COVERAGE:

ALL RISKS

VALUE:

R$ 18.567.680,00

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

CITY:

BANCO ITAÚ S/A

0009    /  19 3735-9709

CAMPINAS/SP

BANCO DO BRASIL S/A

2900-9  /  19 3794-9023

CAMPINAS/SP

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

 

ACTIVITIES COMMENTS

 

THE SUBJECT IS ENGAGED IN THE MANUFACTURE AND TRADE OF PHARMACEUTICAL PRODUCTS.

 

 

IMPORT AND EXPORT:

 

   IMPORTS FROM:

 

ITALY, GERMANY, FRANCE, CANADA, INDIA AND SWEDEN.

 

 

   EXPORTS TO:

 

DOES NOT EXPORT.

 

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

CITY:

PHONE:

DIST.DE DROGAS NORFARMA LTDA

ARAÇATUBA/SP

18 623-3645

DISTR. FARMACÊUTICA PANARELLO LTDA

GOIÂNIA/GO

62 3285-6611

DISTR. MEDICAMENTOS SANTA CRUZ LTDA

CURITIBA/PR

41 3316-2209

DISTR.DROGAS CENTRO OESTE LTDA.

CAMPO GRANDE/MS

67 382-6188

ITA REPRES. PRODS. FARMACÊUTICOS

SANTA BÁRBARA D´OESTE/SP

19 3459-4000

JAMYR VASCONCELOS S/A

RIO DE JANEIRO/RJ

21 2472-2828

PERFORMA DISTR. PRODS. FARMACÊUTICOS LTDA

RIACHO DAS PEDRAS/MG

21 3450-1416

UNIFARMA DISTRIBUISDORA FARMACEUTICA LTDA

IMPERATRIZ/MA

98 3525-3486

 

STAFF:

 

THE COMPANY HAS: 4061 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS AN OLD-ESTABLISHED COMPANY, OPERATING SINCE 1964 WITH A LEADING MARKET POSITION. IT HAS A HIGH AND GROWING SCALE OF ACTIVITIES AND AN EXCELLENT TRADE REPUTATION.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

THE LAWSUITS REPORTED ARE NOT RELATED WITH TRADE DEBTS. THEY ARE RELATED TO TAX DEBTS THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUITS DO NOT AFFECT THE COMPANY'S TRADE REPUTATION.

 

OUR INVESTIGATION THROUGH THE PUBLIC SHOWED SOME DETRIMENTAL FILES REGISTERED AGAINST THE SUBJECT BUT DUE TO THE SUBJECT’S HIGH FINANCIAL STRENGTH AND HIGH SCALE OF OPERATIONS THE DETRIMENTAL FILES ARE CONSIDERED NORMAL AND DO NOT AFFECT ITS TRADE REPUTATION OR ITS CREDITWORTHINESS.

 

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

CITY:

PHONE:

ALLPLAS INDÚSTRIA.COM.PLÁSTICOS LTDA

CARAPICUIBA/SP

11 429-7443

BAFEMA S/A INDÚSTRIA E COMÉRCI0

SÃO PAULO/SP

11 246-4088

BOAINAIN DIOSTR. DE ALCOOL LTDA

OSASCO/SP

11 703-7111

CIA. UNIÃO REFINADORES AÇÚCAR E CAFÉ

SÃO PAULO/SP

11 291-6111

COLORCON DO BRASIL LTDA

COTIA/SP

11 4617-8640

ESQYEMA IND.COM.EMBALAGENS LTDA

OSASCO/SP

11 703-1577

FENIL QUÍMICA LTDA

SÃO PAULO/SP

11 548-9332

HENRIFARMA PRODS.QUI.FARM. LTDA

SÃO PAULO/SP

11 549-9933

M. CASSAB COMERCIO E INDUSTRIA LTDA

SÃO PAULO/SP

11 2162-7788

PRODUTOS ROCHE QUÍM. FARMACÊUTICA S/A

SÃO PAULO/SP

11 268-7022

VEDAT TAMPAS HERMETICAS LTDA

EMBU/SP

11 2133-1212

VITROSUL IND.COM.VIDORS LTDA

EMBÚ/SP

11 494-6877

VULCAN MARTERIAL PLÁSTICO S/A

RIO DE JANEIRO/RJ

21 3362-2037

WHEATON DO BRASIL S/A

SÃO BERNARDO CAMPO/SP

11 451-4433

 

 

PAYMENT HISTORY:

 

30 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 2.992.765,00

 

AMOUNT OF INVOICES PAID: 120

TOTAL OF PROMPT PAYMENTS: 97,3%

TOTAL OF DELAYED PAYMENTS: 2,7%

 

HIGHEST INVOICE: R$ 196.781,00

HIGHEST CREDIT: R$ 196.781,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

3

4

R$ 65.364,19

 

 

FINAL OPINION

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL YEARS. UP TO DATE IT HAS CLEAR TRADE HISTORY AND GOOD PAYMENT PERFORMANCE.

 

BASED ON THE OVERALL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S SIZE AND FINANCIAL STRENGTH.

 

AN INITIAL CREDIT LIMIT OF USD 5.000.000,00 CAN BE CONSIDERED. HIGHER AMOUNTS CAN BE GRANTED DEPENDING ON THE IMPORTANCE OF THE OPERATIONS TO BE ESTABLISHED WITH THE SUBJECT.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 64.03

UK Pound

1

Rs. 99.27

Euro

1

Rs. 71.90

 

INFORMATION DETAILS

 

Analysis Done by :

KRN

 

 

Report Prepared by :

ASH

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.